共 50 条
Endostar plus gemcitabine/cisplatin (GP) with maintenance endostar as first-line therapy for advanced non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
被引:0
|作者:
Lu, You
Huang, Meijuan
Fan, Qingxia
Wu, Qi
Wang, Jin
Li, Lu
Zhang, Xi
Guo, Chengye
Li, Wenhui
Peng, Feng
Ouyang, Xuenong
Yu, Ding
Cai, Xiaohong
Xu, Yong
Hou, Mei
Luo, Rongcheng
Zhang, Tao
机构:
[1] Sichuan Univ, Dept Thorac Oncol, State Key Lab Biotherapy, Huaxi Hosp, Chengdu 610064, Peoples R China
[2] Sichuan Univ, Dept Thorac Oncol, Ctr Canc, West China Hosp, Chengdu 610064, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[4] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China
[5] Sichuan Univ, Dept Thorac Oncol, Ctr Canc, West China Hosp,Med Sch, Chengdu 610064, Peoples R China
[6] Third Peoples Hosp Chengdu, Chengdu, Peoples R China
[7] Qingdao Municipal Hosp, Qingdao, Peoples R China
[8] Yunnan Canc Hosp, Kunming, Peoples R China
[9] Nanjing Mil Command, Fuzhou Gen Hosp, Fuzhou, Peoples R China
[10] Hubei Canc Hosp, Wuhan, Peoples R China
[11] Sichuan Canc Hosp, Chengdu, Peoples R China
[12] Guangzhou Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[13] Chengdu Mil Gen Hosp, Chengdu, Peoples R China
关键词:
D O I:
暂无
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
e18033
引用
收藏
页数:1
相关论文